BeautyHealth to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
Rhea-AI Summary
BeautyHealth (NASDAQ:SKIN) will report Q4 and full-year 2025 financial results after market close on March 12, 2026.
The company will host an investor conference call at 4:30 p.m. ET the same day with a live webcast and supporting materials on https://investors.beautyhealth.com. A recording will be available about three hours after the call concludes.
Positive
- None.
Negative
- None.
News Market Reaction – SKIN
In the Feb 26 session, SKIN gained 9.41%, reflecting a notable positive market reaction. Argus tracked a peak move of +14.2% during that session. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Consumer trends report | Positive | -0.6% | Skintuition report highlighting strong demand for skin regeneration treatments. |
| Nov 06 | Q3 2025 earnings | Positive | +8.5% | Improved gross margin, narrower net loss, stronger adjusted EBITDA and guidance. |
| Nov 03 | Board appointment | Positive | +0.7% | Appointment of experienced aesthetics and healthcare executive to board committees. |
| Oct 23 | Earnings date notice | Neutral | -2.3% | Announcement of Q3 2025 reporting date and call logistics for investors. |
| Sep 30 | CEO transition | Neutral | -10.8% | New CEO appointed with medical device background, predecessor moving to advisory role. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has produced mixed reactions: strategic and earnings updates often aligned with price moves, while consumer insights and information-only releases sometimes coincided with mild pressure.
Over the last few months, SKIN has highlighted consumer demand trends, management changes, and Q3 2025 results. Earnings on Nov 6, 2025 showed $70.7M net sales with improved margins and a narrower net loss, drawing a positive 8.53% reaction. Board and CEO appointments in late 2025 reflected ongoing leadership reshaping. Prior to this earnings-date release, a similar Q3 reporting notice on Oct 23, 2025 drew a modest -2.26% move, suggesting scheduling announcements alone have had limited impact.
Key Terms
investor relations website financial
Regulation FD regulatory
webcast technical
Securities and Exchange Commission regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.
A live webcast of the call can be accessed on the Company’s investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion.
Disclosure Information
The Beauty Health Company announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls and on its investor relations website (https://investors.beautyhealth.com) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
About Us
The Beauty Health Company (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp powered by Keravive™, BeautyHealth combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at beautyhealth.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
Investors: IR@beautyhealth.com
Press: press@beautyhealth.com